MORNING BID 🔸 $NET: Upgraded to Buy by Citigroup, target price to $145 from $95, expecting 27%-30% annual revenue growth. 🔸 Citigroup: Positive 90-day watchlist for $OKTA, negative for $CRWD. 🔸 $WDC: Q2 revenue expected at $4.30B (below consensus $4.24B, EPS at $1.75-$2.05; CFO Jabre resigning. 🔸 $CRM: Upgraded to Buy from Hold by TD Cowen. 🔸 TikTok: Trump's advisor supports keeping app if deal viable; Schumer urges Biden to extend shutdown deadline by 90 days. 🔸 $OZK: Q4 EPS $1.56 vs. est. $1.44; NII $379-398M; book value up 11.5% to $47.30/share. 🔸 $CFG: Q4 EPS $0.85 vs. est. $0.83; revenue $1.99B; NIM 2.87%; provisions $162M. 🔸 $INDB: Q4 adj. EPS $1.21 vs. est. $1.16; NIM 3.33%; Q3 pre-tax profit $62.93M. 🔸 $RC: Announces $150M share buyback. 🔸 $RF: Q4 EPS $0.56 vs. est. $0.55; revenue $1.845B; Q1 NII to decline; NIM 3.55%; provisions $120M. 🔸 $WULF: Files for mixed shelf offering, size undisclosed. 🔸 $TFC: Q4 EPS $0.91 vs. est. $0.88; revenue $5.11B; tangible book value $30.01/share; CET1 ratio 11.5%; provisions $471M; Q1 revenue down 2% Q/Q; FY revenue up 3-3.5%. 🔸 $JBHT: Q4 EPS $1.53 vs. est. $1.61; revenue down 5% to $3.15B, due to declines in various segments including Intermodal (down 2%). 🔸 $DD and $AXTA: Upgraded to Outperform by Wolfe Research. 🔸 $OTIS: Authorizes $2B share repurchase program. 🔸 Shield AI: In talks to raise significant funding from $PLTR and $LMT, per The Information. 🔸 $CROX: Downgraded to Hold from Buy by Williams Trading due to weakening trends. 🔸 $RIVN: Finalizes $6.6B loan agreement with U.S. DOE for Georgia manufacturing. Fisker: U.S. auto safety probe closed on 6,971 Ocean SUVs, no further investigation expected post-bankruptcy.

#Downgrades - Dec 05, 2024 • $ABBV: Daiwa Securities Downgrades to Neutral from Buy - PT $180 • $AEO: JPMorgan Downgrades to Neutral from Overweight - PT $23 (from $27) • $ALLY: Wolfe Research Downgrades to Peerperform from Outperform • $AMAT: Morgan Stanley Downgrades to Underweight from Equalweight - PT $164 (from $179) • $CHWY: BNP Paribas Downgrades to Neutral from Outperform - PT $30 • $CNX: JPMorgan Downgrades to Underweight from Neutral - PT $37 (from $31) • $DVN: JPMorgan Downgrades to Neutral from Overweight - PT $191 • $F: Wolfe Research Downgrades to Underperform from Peerperform • $FOUR: Benchmark Downgrades to Hold from Buy • $FWONA: Seaport Global Securities Downgrades to Neutral from Buy • $GRAB: HSBC Downgrades to Hold from Buy - PT $5.50 (from $4.25) • $MRVI : Goldman Sachs Downgrades to Sell from Neutral - PT $4.25 (from $7) • $NAUT: Goldman Sachs Downgrades to Sell from Neutral - PT $1.75 (from $2.25) • $NCNO: Piper Sandler Downgrades to Neutral from Overweight - PT $38 • $OTIS: Barclays Downgrades to Underweight from Equalweight - PT $94 • $PB: Wolfe Research Downgrades to Peerperform from Outperform • $PFG: Morgan Stanley Downgrades to Underweight from Equalweight - PT $80 (from $86) • $RLMD: Mizuho Downgrades to Neutral from Outperform - PT $1 (from $23) • $ROP: Barclays Downgrades to Underweight from Overweight - PT $569 (from $625) • $SBRA: Mizuho Downgrades to Neutral from Outperform - PT $20 • $SM: JPMorgan Downgrades to Neutral from Overweight - PT $16 (from $15) • $VCYT: Goldman Sachs Downgrades to Neutral from Buy - PT $37 (from $38)

#Downgrades - Oct 08, 2024 $ALB: CFRA Downgrades to Hold from Buy - PT $99 $AXP: HSBC Downgrades to Hold from Buy $AXP: BTIG Downgrades to Sell from Neutral - PT $230 $BUD: TD Cowen Downgrades to Hold from Buy - PT $68 $CME: Redburn-Atlantic Downgrades to Neutral from Buy - PT $244 $FYBR: TD Cowen Downgrades to Hold from Buy - PT $38.50 (from $39) $MSFT: Oppenheimer Downgrades to Perform from Outperform $OMF: Barclays Downgrades to Equalweight from Overweight - PT $46 (from $52) $OTIS: Wolfe Research Downgrades to Peerperform from Outperform $QCOM: KeyBanc Downgrades to Sector Weight from Overweight $STZ: TD Cowen Downgrades to Hold from Buy - PT $270 (from $300) $SYNA: KeyBanc Downgrades to Sector Weight from Overweight